Lipitor, Atorvastatin Newswire (Page 2)

Lipitor, Atorvastatin Newswire (Page 2)

Comprehensive Real-Time News Feed for Lipitor, Atorvastatin (generic). (Page 2)

Results 21 - 40 of 785 in Lipitor, Atorvastatin (generic)

  1. Running Helped This Cardiologist Get off His Blood Pressure and Cholesterol MedicationsRead the original story w/Photo

    Tuesday Apr 4 | Runner's World

    What prompted you to start? I started running to rehab from a left knee arthroscopy. But I also wanted to lose weight, get healthy, and feel good again.

    Comment?

  2. Electrocardiographic changes mimicking acute coronary syndrome in a...Read the original story w/Photo

    Monday Apr 3 | BioMed Central

    ST elevation Myocardial infarction is a medical emergency. A variety of noncardiac conditions had been known to mimic the ECG changes that are seen in acute coronary syndrome.

    Comment?

  3. Creation of a Productive, Highly Enantioselective Nitrilase through...Read the original story

    Tuesday Apr 4 | CiteULike

    To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document. Gene site saturation mutagenesis technology is applied for the directed evolution of a nitrilase.

    Comment?

  4. Abstract 188: Hospital and Regional Variation in Use of...Read the original story

    Friday Mar 31 | Circulation

    Background: American College of Cardiology/American Heart Association guidelines published in 2013 recommend high-intensity statins for most adults a75 years of age with ASCVD, the guidelines recommend continuation of tolerated statins or initiation of moderate intensity statins for most patients. Objective: To examine whether guideline concordant use of high-intensity statins following myocardial infarction among Medicare beneficiaries differed by hospital size, medical school affiliation, and region of the US in 2014 .

    Comment?

  5. Abstract 007: Titration From Low/moderate to High Intensity Statins...Read the original story

    Friday Mar 31 | Circulation

    Background: High intensity statins have been shown to lower the risk of major cardiovascular events after a myocardial infarction . Recent studies report that most people with diabetes who experience a coronary heart disease event are already taking a statin, but little is known about the percentage who are titrated to a high intensity statin following hospital discharge for a MI.

    Comment?

  6. Abstract 087: Impact of High Intensity Statin on Biologic and...Read the original story

    Friday Mar 31 | Circulation

    Background: The metabolic syndrome increases the risk of cardiovascular disease in both men and women. This risk is higher in women.

    Comment?

  7. Bristol-Myers Squibb Who? Why Pfizer Could be Making Googly Eyes at This Michigan Biotech InsteadRead the original story

    Sunday Apr 2 | BioSpace

    Pfizer Inc. is back in growth mode, and it has been acquiring smaller companies as part of its effort to boost revenue and profitability. Given that it shuttered its research into the PCSK9 cholesterol lowering candidate drug bococizumab last November, perhaps the company might now want to set its sights on buying a startup that's working in this indication.

    Comment?

  8. Vaccines Are Pharma's New Profit Center but They Aren't as Safe as Pharma Wants You To ThinkRead the original story w/Photo

    Saturday Apr 1 | OpEdNews

    If you think you have been hearing a lot about vaccines lately, you are right. Since Pharma's blockbuster pills like Lipitor, Viagra, Seroquel, Zyprexa, Singular, Concerta, Cymbalta and Abilify went off patent, its new profit center is biologics--vaccines and other liquid drugs that have to be injected.

    Comment?

  9. Unwanted side effects: Oat beta-glucan beats out plant stanols in cholesterol-lowering studyRead the original story w/Photo

    Friday Mar 31 | NutraIngredients

    While plant stanol esters have a bigger effect on lowering cholesterol than oat beta-glucans, they can come with unwanted side effects including weight gain and microbiome disturbance, finds a new study. Research from the APC Microbiome Institute in Cork, Ireland, tested the effectiveness of plant stanol esters and beta glucans for cholesterol - an area where both have been well documented to have beneficial effects.

    Comment?

  10. Could Pfizer Buy Esperion Therapeutics?Read the original story w/Photo

    Friday Mar 31 | The Motley Fool

    Acquisition hungry Pfizer might want to add this intriguing, clinical-stage biotech company to its arsenal for its candidate cholesterol drug. is back in growth mode, and it has been acquiring smaller companies as part of its effort to boost revenue and profitability.

    Comment?

  11. A comparison of generic drug prices in seven European countries: a methodological analysisRead the original story w/Photo

    Thursday Mar 30 | BioMed Central

    Policymakers and researchers frequently compare the prices of medicines between countries. Such comparisons often serve as barometers of how pricing and reimbursement policies are performing.

    Comment?

  12. The 3 Best Cholesterol Drug Stocks to Buy in 2017Read the original story w/Photo

    Thursday Mar 30 | Fox News

    No cholesterol drug is likely to ever reach the sales level that Lipitor was able to achieve, but investors can still profit buying stock in companies developing drugs for patients with high cholesterol where Lipitor or other statins aren't enough to bring patients' cholesterol levels down. The Medicines Company , Esperion Therapeutics , and Regeneron Pharmaceuticals are all poised to progress their cholesterol drugs in 2017.

    Comment?

  13. Repatha Offers Additional LDL-C Reduction in a Convenient Dosage FormRead the original story w/Photo

    Thursday Mar 30 | The American Journal of Managed Care

    Richard Mullvain, RPh, BCPS , CCCC, a cardiovascular clinical pharmacist and expert in cardiovascular care at the Essentia Health Heart & Vascular Center in Duluth Minnesota, delivered a focused clinical review on the topic of the PCSK9 inhibitor Repatha , and its impact on low-density lipoprotein cholesterol .

    Comment?

  14. Top 5 Vendors in the Global Dyslipidemia Drugs Market from 2017 to 2021: TechnavioRead the original story w/Photo

    Mar 29, 2017 | Customer Interaction Solutions

    This market research report also lists 17 other prominent vendors that are expected to impact the market during the forecast period. According to the research analysis, the global dyslipidemia drugs market is highly competitive with the presence of numerous small and large vendors.

    Comment?

  15. Wife of London Terrorist: 'Saddened and Shocked' by AttackRead the original story w/Photo

    Mar 29, 2017 | The Oak Ridge Observer

    Four people were killed and dozens of others were wounded when Masood drove a rental vehicle through a throng of civilians on Westminster Bridge, then assaulted a police officer with a knife at the gates of the Parliament building. "We are tracing these people, but I would ask you all to voluntarily come forward and help our investigation", said Basu.

    Comment?

  16. Indonesian man found dead in belly of 7m-long pythonRead the original story w/Photo

    Mar 29, 2017 | The Oak Ridge Observer

    Akbar Salubiro , 25, had not been seen since setting off to harvest palm oil in a remote village on the island of Sulawesi. Friends and family have expressed shock and dismay after a caught python was cut up only to expose the remains of 25 year old Indonesian man, Akbar Salubiro .

    Comment?

  17. Atorvastatin Market is expected to Rise at a Remarkable CAGR By 2022Read the original story

    Mar 29, 2017 | Emailwire.com

    ReportsWeb has announced the addition of the 'Global Atorvastatin Market by Manufacturers, States, Type and Application, Forecast to 2022' report to their offering. This report provides valuable source of guidance for manufacturers, suppliers, distributor Atorvastatin is a reaction engine discharging a fast-moving jet that generates thrust by jet propulsion.

    Comment?

  18. Statins Warning: Cholesterol-lowering drug found to raise risk of...Read the original story w/Photo

    Mar 27, 2017 | NewsTarget.com

    Elderly women who take statins have an increased risk of developing type-2 diabetes , an Australian study found. Researchers at the University of Queensland examined more than 8,000 elderly female pensioners and found that those who took the cholesterol-lowering drug had a 33% increased risk of diabetes.

    Comment?

  19. Is this drug worth the cost? Cholesterol drug cuts heart risks, spurs new debateRead the original story w/Photo

    Mar 24, 2017 | Berkshire Eagle

    A long-acting cholesterol medicine cut the risk of having a heart attack or some other serious problems by 15 to 20 percent in a big study that's likely to spur fresh debate about what drugs should cost. Statins such as Lipitor and Crestor are cheap and lower LDL or bad cholesterol, but some people can't tolerate or get enough help from them.

    Comment?

  20. IMS Health: Pharm Markets Projected To Grow At 7.8% Per YearRead the original story

    Dec 31, 1995 | Pharmaceutical Online

    According to a new study by IMS Health, the global pharmaceutical market will grow at a 7.8% compound average annual rate during the next five years, reaching $406 billion in sales by 2002. The compound growth rate in North America is expected to be 9.8%, higher than the global average.

    Comment?